Matthew G Pridgeon1,2,3, Patrick J Grohar2,3,4,5, Matthew R Steensma2,3,5,6, Bart O Williams7. 1. Grand Rapids Medical Education Partners, Grand Rapids, MI, USA. 2. Spectrum Health Cancer Center, Spectrum Health System, Grand Rapids, MI, USA. 3. Helen De Vos Children's Hospital, Grand Rapids, MI, USA. 4. Department of Pediatrics, Michigan State University, Grand Rapids, MI, USA. 5. Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI, USA. 6. Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, MI, USA. 7. Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, MI, USA. Bart.williams@vai.org.
Abstract
PURPOSE OF REVIEW: Wnt signaling plays a central role in development and homeostasis, and its dysregulation is a common event in many types of human cancer. Here we explore in detail the contributions of Wnt signaling to the initiation and maintenance of three types of saroma: Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. This review provides an overview of the Wnt signaling pathway and explores in detail the current knowledge about its role in the initiation or maintenance of three tumor types: Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. RECENT FINDINGS: Recent work has assessed the role(s) of Wnt signaling within these cell types. This review provides an overview of the mechanistic insights that have been gained from a number of recent studies to set the foundation for potential therapeutic applications. Wnt signaling has emerged as a potentially critical pathway in maintaining the growth of these types of tumors. Given the fact that many new inhibitors of the pathway have recently or will soon enter Phase 1 clinical trials, it is likely that assessment of their activity in these tumor types will occur in human patients.
PURPOSE OF REVIEW: Wnt signaling plays a central role in development and homeostasis, and its dysregulation is a common event in many types of human cancer. Here we explore in detail the contributions of Wnt signaling to the initiation and maintenance of three types of saroma: Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. This review provides an overview of the Wnt signaling pathway and explores in detail the current knowledge about its role in the initiation or maintenance of three tumor types: Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. RECENT FINDINGS: Recent work has assessed the role(s) of Wnt signaling within these cell types. This review provides an overview of the mechanistic insights that have been gained from a number of recent studies to set the foundation for potential therapeutic applications. Wnt signaling has emerged as a potentially critical pathway in maintaining the growth of these types of tumors. Given the fact that many new inhibitors of the pathway have recently or will soon enter Phase 1 clinical trials, it is likely that assessment of their activity in these tumor types will occur in human patients.
Authors: O Delattre; J Zucman; B Plougastel; C Desmaze; T Melot; M Peter; H Kovar; I Joubert; P de Jong; G Rouleau Journal: Nature Date: 1992-09-10 Impact factor: 49.962
Authors: Martin S Staege; Christoph Hutter; Ingo Neumann; Sabine Foja; Uwe E Hattenhorst; Gesine Hansen; Danny Afar; Stefan E G Burdach Journal: Cancer Res Date: 2004-11-15 Impact factor: 12.701
Authors: Kristin Baird; Sean Davis; Cristina R Antonescu; Ursula L Harper; Robert L Walker; Yidong Chen; Arthur A Glatfelter; Paul H Duray; Paul S Meltzer Journal: Cancer Res Date: 2005-10-15 Impact factor: 12.701
Authors: Bang H Hoang; Tadahiko Kubo; John H Healey; Rui Yang; Saminathan S Nathan; E Anders Kolb; BethAnne Mazza; Paul A Meyers; Richard Gorlick Journal: Cancer Res Date: 2004-04-15 Impact factor: 12.701
Authors: Aykut Uren; Vladimir Wolf; Yu-Feng Sun; Amir Azari; Jeffrey S Rubin; Jeffrey A Toretsky Journal: Pediatr Blood Cancer Date: 2004-09 Impact factor: 3.167